These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17269706)

  • 1. Tumour metabolomics in animal models of human cancer.
    Griffin JL; Kauppinen RA
    J Proteome Res; 2007 Feb; 6(2):498-505. PubMed ID: 17269706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metabolomics perspective of human brain tumours.
    Griffin JL; Kauppinen RA
    FEBS J; 2007 Mar; 274(5):1132-9. PubMed ID: 17298437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiles of cancer cells.
    Griffin JL; Shockcor JP
    Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
    Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
    BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers.
    Yeh IT; Ludueña RF
    Cell Motil Cytoskeleton; 2004 Feb; 57(2):96-106. PubMed ID: 14691949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor models and specific contrast agents for small animal imaging in oncology.
    Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G
    Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy of neoplasms.
    Maris JM; Chance B
    Magn Reson Annu; 1986; ():213-35. PubMed ID: 3079339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies.
    Tzika AA; Astrakas L; Cao H; Mintzopoulos D; Andronesi OC; Mindrinos M; Zhang J; Rahme LG; Blekas KD; Likas AC; Galatsanos NP; Carroll RS; Black PM
    Int J Mol Med; 2007 Aug; 20(2):199-208. PubMed ID: 17611638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raman spectroscopy can differentiate malignant tumors from normal breast tissue and detect early neoplastic changes in a mouse model.
    Kast RE; Serhatkulu GK; Cao A; Pandya AK; Dai H; Thakur JS; Naik VM; Naik R; Klein MD; Auner GW; Rabah R
    Biopolymers; 2008 Mar; 89(3):235-41. PubMed ID: 18041066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy.
    Ellis DI; Goodacre R
    Analyst; 2006 Aug; 131(8):875-85. PubMed ID: 17028718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications.
    Soares DP; Law M
    Clin Radiol; 2009 Jan; 64(1):12-21. PubMed ID: 19070693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for cancer treatment: progress and promise.
    Sarfaraz S; Adhami VM; Syed DN; Afaq F; Mukhtar H
    Cancer Res; 2008 Jan; 68(2):339-42. PubMed ID: 18199524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
    Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
    Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of de novo synthesized proteins released from human colorectal tumour explants.
    Shi HJ; Stubbs R; Hood K
    Electrophoresis; 2009 Jul; 30(14):2442-53. PubMed ID: 19639566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW; Cheng LL
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurospecific proteins: potentials and prospects for their use in morphological research on tumors].
    Zhmareva EN; Brodskaia IA; Berezin VA; Shevchenko GM
    Arkh Patol; 1987; 49(4):87-91. PubMed ID: 3300612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
    Morvan D; Demidem A
    Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.